HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
Academic Article
Publication Date:
2010
abstract:
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
Iris type:
14.a.1 Articolo su rivista
Keywords:
HCV genotype 2; B-cell lymphoma; rituximab
List of contributors:
Pitini, Vincenzo; Sturniolo, Giuseppe; Arrigo, Carmela; Leonardi, Maria Silvana; Pino, S; Altavilla, Giuseppe
Published in: